These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21326109)

  • 1. Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model.
    Kellar RS; Lancaster JJ; Thai HM; Juneman E; Johnson NM; Byrne HG; Stansifer M; Arsanjani R; Baer M; Bebbington C; Flashner M; Yarranton G; Goldman S
    J Cardiovasc Pharmacol; 2011 May; 57(5):568-74. PubMed ID: 21326109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
    Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
    J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.
    Yano T; Miura T; Whittaker P; Miki T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ohori K; Shimamoto K
    J Am Coll Cardiol; 2006 Feb; 47(3):626-34. PubMed ID: 16458148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
    Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
    Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
    Villarreal FJ; Griffin M; Omens J; Dillmann W; Nguyen J; Covell J
    Circulation; 2003 Sep; 108(12):1487-92. PubMed ID: 12952845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
    Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
    Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
    Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
    Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
    J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swimming exercise training prior to acute myocardial infarction attenuates left ventricular remodeling and improves left ventricular function in rats.
    Dayan A; Feinberg MS; Holbova R; Deshet N; Scheinowitz M
    Ann Clin Lab Sci; 2005; 35(1):73-8. PubMed ID: 15830712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
    Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.